Havemeyer Place’s GSK GSK Stock Holding History

Havemeyer Place’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,216	Closed	-$1.38M	–	597
2025 Q4	$1.38M	Buy	+28,216	New	+$1.32M	0.27%	117

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Havemeyer Place's GSK Position: Q1 2026 in Review

Havemeyer Place sold out of GSK (GSK) in Q1 2026, closing a stake of 28,216 shares — an estimated $1.38M sold.

Havemeyer Place first reported a position in GSK in Q4 2025 and held it in 1 quarter. The position peaked at $1.38M in Q4 2025. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Havemeyer Place reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Havemeyer Place sold 28,216 GSK shares in Q1 2026, an estimated $1.38M.
Havemeyer Place first reported a position in GSK in Q4 2025 and held it in 1 quarter.
Havemeyer Place's GSK position peaked at $1.38M in Q4 2025.
1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Havemeyer Place's 13F filing for Q1 2026, filed 13 May 2026.